New long-term extension data from the Phase IIb/III QUASAR trial demonstrate that Tremfya (guselkumab) maintains durable clinical and endoscopic remission through 92 weeks in adults with moderately to ...

Johnson & Johnson today announced new data from the TREMFYA® (guselkumab) Phase 3 QUASAR long-term extension (LTE) study in adults with moderately-to-severely active ulcerative colitis (UC). These ...

The fourth-gen Chevy Corvette ZR-1 was a performance tour de force. This Quasar Blue copy will soon cross the Mecum Auctions ...

Jokić, a strong candidate to win his 4th Kia NBA MVP award, joins current teammate Russell Westbrook and Oscar Robertson. Associated Press Nuggets star Nikola Jokić finished Friday’s victory ...